Upstream Bio Inc (UPB) USD0.001

Sell:$9.17Buy:$9.18Price decreased$0.46 (4.84%)

NASDAQ:Price increased0.04%
Market closed |
Prices delayed by at least 15 minutes
Sell:$9.17
Buy:$9.18
Change:Price decreased$0.46 (4.84%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$9.17
Buy:$9.18
Change:Price decreased$0.46 (4.84%)
Market closed |
Prices delayed by at least 15 minutes

Key metrics

Open$9.32
Previous close$9.51
Market cap$517.53m
P/E ratio-
Volume170,593
Dividend yield0.00%
EMS-

Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue54.42m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.